-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Downgrades Kymera Therapeutics to Peer Perform

Benzinga·01/06/2026 13:19:58
語音播報
Wolfe Research analyst Andy Chen downgrades Kymera Therapeutics (NASDAQ:KYMR) from Outperform to Peer Perform.